MVM IV LP
MVM Life Science Partners · adviser of record: MVM Partners LLP · 2013 vintage
MVM IV LP is a 2013 venture fund managed by MVM Life Science Partners, with $27mm raised (Form D, amount sold). It reported $124mm in gross assets at year-end 2025, 4.58x its size, against a peak of $323mm in 2017.
- Latest value held
- $124mm year-end 2025
- Peak
- $323mm year-end 2017
- Fund size
- $27mm Form D, amount sold
- Held vs. size
- 4.58x peak 11.95x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $124mm | 4.58x | -36% over 2 yrs |
| 2023 | $192mm | 7.13x | -6% |
| 2022 | $205mm | 7.60x | -17% |
| 2021 | $248mm | 9.17x | -18% |
| 2020 | $304mm | 11.24x | +21% |
| 2019 | $252mm | 9.33x | -12% |
| 2018 | $288mm | 10.66x | -11% |
| 2017 | $323mm | 11.95x | +17% |
| 2016 | $275mm | 10.19x | +27% |
| 2015 | $216mm | 8.00x | +60% |
| 2014 | $135mm | 4.98x | +27% |
| 2013 | $106mm | 3.91x | – |
Other funds from MVM Life Science Partners
- MVM IV (2019) LP 2019
- MVM IV CO-Investment I LP 2014
- MVM Fund III Limited Partnership 2011
- MVM International Life Sciences No.1 Limited Partnership 2011
- UK Medical Ventures Fund No. 1 Limited Partnership 2011
- MVM Fund III (No.2) Limited Partnership 2011
All MVM Life Science Partners funds
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-6557843345. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.